Gene

Search results

No.	KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related	KEGG GENES	KEGG DRUG	DrugBank	指定難病告示番号
1	AGE-RAGE signaling pathway in diabetic complications 💬	1件: VEGFA 💬	D05697 💬	Ranibizumab	4件: 34, 166, 227, 301 💬
2	AGE-RAGE signaling pathway in diabetic complications 💬	2件: VEGFA, VEGFB 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
3	Bladder cancer 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
4	Bladder cancer 💬	1件: VEGFA 💬	D05697 💬	Ranibizumab	4件: 34, 166, 227, 301 💬
5	Calcium signaling pathway 💬	1件: VEGFA 💬	D05697 💬	Ranibizumab	4件: 34, 166, 227, 301 💬
6	Calcium signaling pathway 💬	2件: VEGFA, VEGFB 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
7	Chemical carcinogenesis - reactive oxygen species 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
8	Chemical carcinogenesis - reactive oxygen species 💬	1件: VEGFA 💬	D05697 💬	Ranibizumab	4件: 34, 166, 227, 301 💬
9	Chemical carcinogenesis - receptor activation 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
10	Chemical carcinogenesis - receptor activation 💬	1件: VEGFA 💬	D05697 💬	Ranibizumab	4件: 34, 166, 227, 301 💬
11	Collecting duct acid secretion 💬	2件: ATP4A, ATP4B 💬	D00355 💬	Lansoprazole	7件: 63, 71, 85, 98, 166, 222, 299 💬
12	EGFR tyrosine kinase inhibitor resistance 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
13	EGFR tyrosine kinase inhibitor resistance 💬	1件: VEGFA 💬	D05697 💬	Ranibizumab	4件: 34, 166, 227, 301 💬
14	Fluid shear stress and atherosclerosis 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
15	Fluid shear stress and atherosclerosis 💬	1件: VEGFA 💬	D05697 💬	Ranibizumab	4件: 34, 166, 227, 301 💬
16	Focal adhesion 💬	3件: PGF, VEGFA, VEGFB 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
17	Focal adhesion 💬	1件: VEGFA 💬	D05697 💬	Ranibizumab	4件: 34, 166, 227, 301 💬
18	Gastric acid secretion 💬	2件: ATP4A, ATP4B 💬	D00355 💬	Lansoprazole	7件: 63, 71, 85, 98, 166, 222, 299 💬
19	HIF-1 signaling pathway 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
20	HIF-1 signaling pathway 💬	1件: VEGFA 💬	D05697 💬	Ranibizumab	4件: 34, 166, 227, 301 💬
21	Human cytomegalovirus infection 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
22	Human cytomegalovirus infection 💬	1件: VEGFA 💬	D05697 💬	Ranibizumab	4件: 34, 166, 227, 301 💬
23	Human papillomavirus infection 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
24	Human papillomavirus infection 💬	1件: VEGFA 💬	D05697 💬	Ranibizumab	4件: 34, 166, 227, 301 💬
25	Kaposi sarcoma-associated herpesvirus infection 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
26	Kaposi sarcoma-associated herpesvirus infection 💬	1件: VEGFA 💬	D05697 💬	Ranibizumab	4件: 34, 166, 227, 301 💬
27	MAPK signaling pathway 💬	3件: PGF, VEGFA, VEGFB 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
28	MAPK signaling pathway 💬	1件: VEGFA 💬	D05697 💬	Ranibizumab	4件: 34, 166, 227, 301 💬
29	Metabolic pathways 💬	2件: ATP4A, ATP4B 💬	D00355 💬	Lansoprazole	7件: 63, 71, 85, 98, 166, 222, 299 💬
30	MicroRNAs in cancer 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
31	MicroRNAs in cancer 💬	1件: VEGFA 💬	D05697 💬	Ranibizumab	4件: 34, 166, 227, 301 💬
32	Oxidative phosphorylation 💬	2件: ATP4A, ATP4B 💬	D00355 💬	Lansoprazole	7件: 63, 71, 85, 98, 166, 222, 299 💬
33	Pancreatic cancer 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
34	Pancreatic cancer 💬	1件: VEGFA 💬	D05697 💬	Ranibizumab	4件: 34, 166, 227, 301 💬
35	Pathways in cancer 💬	3件: PGF, VEGFA, VEGFB 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
36	Pathways in cancer 💬	1件: VEGFA 💬	D05697 💬	Ranibizumab	4件: 34, 166, 227, 301 💬
37	PI3K-Akt signaling pathway 💬	3件: PGF, VEGFA, VEGFB 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
38	PI3K-Akt signaling pathway 💬	1件: VEGFA 💬	D05697 💬	Ranibizumab	4件: 34, 166, 227, 301 💬
39	Proteoglycans in cancer 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
40	Proteoglycans in cancer 💬	1件: VEGFA 💬	D05697 💬	Ranibizumab	4件: 34, 166, 227, 301 💬
41	Rap1 signaling pathway 💬	3件: PGF, VEGFA, VEGFB 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
42	Rap1 signaling pathway 💬	1件: VEGFA 💬	D05697 💬	Ranibizumab	4件: 34, 166, 227, 301 💬
43	Ras signaling pathway 💬	3件: PGF, VEGFA, VEGFB 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
44	Ras signaling pathway 💬	1件: VEGFA 💬	D05697 💬	Ranibizumab	4件: 34, 166, 227, 301 💬
45	Relaxin signaling pathway 💬	1件: VEGFA 💬	D05697 💬	Ranibizumab	4件: 34, 166, 227, 301 💬
46	Relaxin signaling pathway 💬	2件: VEGFA, VEGFB 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
47	Renal cell carcinoma 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
48	Renal cell carcinoma 💬	1件: VEGFA 💬	D05697 💬	Ranibizumab	4件: 34, 166, 227, 301 💬
49	Rheumatoid arthritis 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
50	Rheumatoid arthritis 💬	1件: VEGFA 💬	D05697 💬	Ranibizumab	4件: 34, 166, 227, 301 💬
51	VEGF signaling pathway 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
52	VEGF signaling pathway 💬	1件: VEGFA 💬	D05697 💬	Ranibizumab	4件: 34, 166, 227, 301 💬

先頭へ